Acinetobacter baumannii is recognized as a clinically significant pathogen causing a wide
spectrum of nosocomial infections. Colistin was considered a last-resort antibiotic for the …

This review critically appraises the published microbiologic and clinical data on the
treatment of patients with carbapenem‐resistant Acinetobacter baumannii infections …

This study aimed to investigate the prevalence and resistance mechanisms of colistin-
resistant Acinetobacter baumannii (ColRAB) isolates in Serbia, assess their genetic …

Acinetobacter baumannii is one of the most common multidrug-resistant pathogens causing
nosocomial infections. The prevalence of multidrug-resistant A. baumannii infections is …

Bacterial drug resistance is increasingly becoming an important problem that needs to be
solved urgently in modern clinical practices. Infection caused by Acinetobacter baumannii is …

The progressive increase in the resistance rates to first-and second-line antibiotics has
forced the reuse of colistin as last-line treatment for Acinetobacter baumannii infections, but …

Acinetobacter baumannii is a nosocomial pathogen increasingly affecting the critically ill
patients and represents a major public health challenge. Carbapenem-resistant A …

Antimicrobial resistance to antibiotic treatment has significantly increased during recent
years, causing this to become a worldwide public health problem. More than 70% of …

Although the molecular mechanisms of carbapenem resistance of environmental isolates of
Acinetobacter baumannii are well described, data on the mechanisms of colistin resistance …

Acinetobacter baumannii is a leading cause of healthcare-associated infections worldwide.
The clinical significance of A. baumannii lies in its ability to acquire multiple resistance …